Pharmaceutical

Multiply Labs and GenScript partner on cell isolation automation

Robotics company Multiply Labs has partnered with global life-sciences service provider GenScript Biotech to automate the cell isolation phase in cell therapy manufacturing.

Apr 27, 2024 - 00:00
Multiply Labs and GenScript partner on cell isolation automation
Robotics company Multiply Labs has partnered with global life-sciences service provider GenScript Biotech to automate the cell isolation phase in cell therapy manufacturing.
Read the original article

Tags:

Previous Article

Merck’s net income for Q1 2024 increases by 69% to $4.76bn

Next Article

Regeneron and Mammoth team up to develop gene editing therapies

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

AstraZeneca reports positive Phase III results for Imfinzi in small cell lung cancer

AstraZeneca reports positive Phase III results for Imfi...

Apr 7, 2024

STAT+: Muzzled for years, vindicated MIT professor says fraud investigation into his lab did lasting damage

STAT+: Muzzled for years, vindicated MIT professor says...

Jun 14, 2023

Listen: Explaining the E.U.’s pharma overhaul, Lilly’s booming business, & a long-awaited drug approval

Listen: Explaining the E.U.’s pharma overhaul, Lilly’s ...

Apr 27, 2023